SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-017608
Filing Date
2023-01-27
Accepted
2023-01-27 16:32:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d395334ds3.htm S-3 250297
2 EX-5.1 d395334dex51.htm EX-5.1 3535
3 EX-23.1 d395334dex231.htm EX-23.1 1767
4 EX-23.2 d395334dex232.htm EX-23.2 1651
5 EX-23.3 d395334dex233.htm EX-23.3 1973
6 EX-FILING FEES d395334dexfilingfees.htm EX-FILING FEES 29832
7 GRAPHIC g395334g34g03.jpg GRAPHIC 75799
  Complete submission text file 0001193125-23-017608.txt   394844
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269443 | Film No.: 23563633
SIC: 2836 Biological Products, (No Diagnostic Substances)